Literature DB >> 2360710

[Bicarbonate instead of lactate buffered substitution solution for continuous hemofiltration in intensive care].

C J Olbricht1, D Huxmann-Nägeli, H Bischoff.   

Abstract

The substitution fluids applied in continuous haemofiltration contain 40 mmol/l of lactate. This is unphysiological, since administration of large amounts of lactate lowers the phosphorylation potential and increases catabolism. With bicarbonate-buffered fluid three problems may arise: 1. Precipitation of calcium carbonate and magnesium carbonate; 2. pH is usually 8.4; 3. evaporation of CO2 increases pH. To solve these problems we applied a two-component system consisting of a glass bottle with 160 ml sodium bicarbonate 8.4% and a bag with 4.5 l of acidic solution. Prior to use, the bicarbonate was infused into the bag. The values of Ca++, Mg++, bicarbonate, and pH in this final substitution solution were constant during a 24 hr period after mixing. Precipitation of Ca++ and Mg++ carbonate was prevented by 3 mmol/l of lactic acid in the solution. The pH was 7.37. Evaporation of CO2 was prevented by bags made of special plastic sheeting. The solution was then applied in 7 intensive-care patients suffering from acute renal failure treated by continuous arteriovenous haemofiltration. No side effects of the solution were observed during six days of treatment. The values of Ca++, bicarbonate, pH, and pCO2 remained constant under clinical routine conditions. Hence, bicarbonate-buffered substitution solution is recommended for continuous haemofiltration. Continuous haemofiltration is now also available for patients with impaired liver function and increased lactate levels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2360710

Source DB:  PubMed          Journal:  Anasth Intensivther Notfallmed        ISSN: 0174-1837


  1 in total

1.  Total hepatectomy and liver transplantation as two-stage procedure.

Authors:  B Ringe; N Lübbe; E Kuse; U Frei; R Pichlmayr
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.